Pei et al. (2020) alleviated the behavioral deficits in Fmr1 KO mice through genetic ICAM5 intervention, which may provide therapeutic benefits for the treatment of FXS cognitive impairment and other neurodevelopmental disorders. Here, ICAM5 is linked to fragile X syndrome.